CoChat
Sign Up
Cited by 79

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Regulation of mTOR Activity in Snell Dwarf and GH Receptor Gene-Disrupted Mice

Dominick, Graham, Berryman, Darlene E., List, Edward O., Kopchick, John J., Li, Xinna, Miller, Richard A., Garcia, Gonzalo G.·2015·Endocrinology
DOI 10.1210/en.2014-1690
Open this paper in CoChat — free account

Abstract

The involvement of mammalian target of rapamycin (mTOR) in lifespan control in invertebrates, calorie-restricted rodents, and extension of mouse lifespan by rapamycin have prompted speculation that diminished mTOR function may contribute to mammalian longevity in several settings. We show here that mTOR complex-1 (mTORC1) activity is indeed lower in liver, muscle, heart, and kidney tissue of Snell dwarf and global GH receptor (GHR) gene-disrupted mice (GHR−/−), consistent with previous studies. Surprisingly, activity of mTORC2 is higher in fasted Snell and GHR−/− than in littermate controls in all 4 tissues tested. Resupply of food enhanced mTORC1 activity in both controls and long-lived mutant mice but diminished mTORC2 activity only in the long-lived mice. Mice in which GHR has been disrupted only in the liver do not show extended lifespan and also fail to show the decline in mTORC1 and increase in mTORC2 seen in mice with global loss of GHR. The data suggest that the antiaging effects in the Snell dwarf and GHR−/− mice are accompanied by both a decline in mTORC1 in multiple organs and an increase in fasting levels of mTORC2. Neither the lifespan nor mTOR effects appear to be mediated by direct GH effects on liver or by the decline in plasma IGF-I, a shared trait in both global and liver-specific GHR−/− mice. Our data suggest that a more complex pattern of hormonal effects and intertissue interactions may be responsible for regulating both lifespan and mTORC2 function in these mouse models of delayed aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2014-1690

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 11 references

Research works printed but not linked: 76

  1. Evans, 2011, TOR signaling never gets old: aging, longevity and TORC1 activity, Ageing Res Rev, 10, 225, 10.1016/j.arr.2010.04.001 · DOI
  2. Gough, 2012, Focus issue: TOR signaling, a tale of two complexes, Sci Signal, 5, eg4, 10.1126/scisignal.2003044 · DOI
  3. Katewa, 2011, Role of TOR signaling in aging and related biological processes in Drosophila melanogaster, Exp Gerontol, 46, 382, 10.1016/j.exger.2010.11.036 · DOI
  4. Pani, 2011, From growing to secreting: new roles for mTOR in aging cells, Cell Cycle, 10, 2450, 10.4161/cc.10.15.16886 · DOI
  5. Hanrahan, 2006, Rheb activation of mTOR and S6K1 signaling, Methods Enzymol, 407, 542, 10.1016/S0076-6879(05)07044-8 · DOI
  6. Saci, 2011, Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size, Mol Cell, 42, 50, 10.1016/j.molcel.2011.03.017 · DOI · Paper page
  7. Zhou, 2011, Role of mTOR signaling in tumor cell motility, invasion and metastasis, Curr Protein Pept Sci, 12, 30, 10.2174/138920311795659407 · DOI
  8. Patel, 2006, Increased Rheb-TOR signaling enhances sensitivity of the whole organism to oxidative stress, J Cell Sci, 119, 4285, 10.1242/jcs.03199 · DOI
  9. Cannizzo, 2011, Oxidative stress, inflamm-aging and immunosenescence, J Proteomics, 74, 2313, 10.1016/j.jprot.2011.06.005 · DOI
  10. Proud, 2007, Amino acids and mTOR signalling in anabolic function, Biochem Soc Trans, 35, 1187, 10.1042/BST0351187 · DOI
  11. Garami, 2003, Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2, Mol Cell, 11, 1457, 10.1016/S1097-2765(03)00220-X · DOI · Paper page
  12. Shadel, 2009, Multi-faceted regulation of mitochondria by TOR, Cell Cycle, 8, 2143, 10.4161/cc.8.14.9117 · DOI
  13. Alessi, 2009, New insights into mTOR signaling: mTORC2 and beyond, Sci Signal, 2, pe27, 10.1126/scisignal.267pe27 · DOI
  14. Oh, 2011, mTOR complex 2 signaling and functions, Cell Cycle, 10, 2305, 10.4161/cc.10.14.16586 · DOI
  15. Berchtold, 2012, Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis, Nat Cell Biol, 14, 542, 10.1038/ncb2480 · DOI
  16. Niles, 2012, Plasma membrane proteins Slm1 and Slm2 mediate activation of the AGC kinase Ypk1 by TORC2 and sphingolipids in S. cerevisiae, Cell Cycle, 11, 3745, 10.4161/cc.21752 · DOI
  17. Jacinto, 2006, SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity, Cell, 127, 125, 10.1016/j.cell.2006.08.033 · DOI
  18. García-Martínez, 2008, mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1), Biochem J, 416, 375, 10.1042/BJ20081668 · DOI · Paper page
  19. Lamming, 2014, Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan, Aging Cell, 13, 911, 10.1111/acel.12256 · DOI · Paper page
  20. Cameron, 2011, mTORC2 targets AGC kinases through Sin1-dependent recruitment, Biochem J, 439, 287, 10.1042/BJ20110678 · DOI
  21. Xie, 2013, Crosstalk between mTOR complexes, Nat Cell Biol, 15, 1263, 10.1038/ncb2877 · DOI
  22. Liu, 2013, Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis, Nat Cell Biol, 15, 1340, 10.1038/ncb2860 · DOI
  23. Sharp, 2013, Chronic mechanistic target of rapamycin inhibition: preventing cancer to delay aging, or vice versa?, Interdiscip Top Gerontol, 38, 1, 10.1159/000343625 · DOI
  24. Stanfel, 2009, The TOR pathway comes of age, Biochim Biophys Acta, 1790, 1067, 10.1016/j.bbagen.2009.06.007 · DOI
  25. Wu, 2013, Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression, Cell Rep, 4, 913, 10.1016/j.celrep.2013.07.030 · DOI · Paper page
  26. Lamming, 2012, Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity, Science, 335, 1638, 10.1126/science.1215135 · DOI · Paper page
  27. Perkey, 2013, Increased mammalian target of rapamycin complex 2 signaling promotes age-related decline in CD4 T cell signaling and function, J Immunol, 191, 4648, 10.4049/jimmunol.1300750 · DOI
  28. Bonkowski, 2009, Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity, PLoS One, 4, e4567, 10.1371/journal.pone.0004567 · DOI
  29. Giani, 2008, Insulin signaling cascade in the hearts of long-lived growth hormone receptor knockout mice: effects of calorie restriction, J Gerontol A Biol Sci Med Sci, 63, 788, 10.1093/gerona/63.8.788 · DOI
  30. Chandrashekar, 2007, Age-related alterations in pituitary and testicular functions in long-lived growth hormone receptor gene-disrupted mice, Endocrinology, 148, 6019, 10.1210/en.2007-0837 · DOI
  31. Bartke, 2007, Effects of dietary restriction on the expression of insulin-signaling-related genes in long-lived mutant mice, Interdiscip Top Gerontol, 35, 69
  32. Al-Regaiey, 2007, Effects of caloric restriction and growth hormone resistance on insulin-related intermediates in the skeletal muscle, J Gerontol A Biol Sci Med Sci, 62, 18, 10.1093/gerona/62.1.18 · DOI
  33. Bonkowski, 2006, Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction, Proc Natl Acad Sci USA, 103, 7901, 10.1073/pnas.0600161103 · DOI
  34. Al-Regaiey, 2005, Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor I/insulin signaling and caloric restriction, Endocrinology, 146, 851, 10.1210/en.2004-1120 · DOI
  35. Bartke, 2004, Life extension in the dwarf mouse, Curr Top Dev Biol, 63, 189, 10.1016/S0070-2153(04)63006-7 · DOI
  36. Liang, 2003, Genetic mouse models of extended lifespan, Exp Gerontol, 38, 1353, 10.1016/j.exger.2003.10.019 · DOI
  37. Hsieh, 2002, Implications for the insulin signaling pathway in Snell dwarf mouse longevity: a similarity with the C. elegans longevity paradigm, Mech Ageing Dev, 123, 1229, 10.1016/S0047-6374(02)00036-2 · DOI
  38. Dozmorov, 2002, Gene expression profile of long-lived snell dwarf mice, J Gerontol A Biol Sci Med Sci, 57, B99, 10.1093/gerona/57.3.B99 · DOI
  39. Flurkey, 2001, Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production, Proc Natl Acad Sci USA, 98, 6736, 10.1073/pnas.111158898 · DOI · Paper page
  40. Junnila, 2013, The GH/IGF-1 axis in ageing and longevity, Nat Rev Endocrinol, 9, 366, 10.1038/nrendo.2013.67 · DOI · Paper page
  41. Anisimov, 2013, The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer, Crit Rev Oncol Hematol, 87, 201, 10.1016/j.critrevonc.2013.01.005 · DOI · Paper page
  42. Kenyon, 2011, The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing, Philos Trans R Soc Lond B Biol Sci, 366, 9, 10.1098/rstb.2010.0276 · DOI · Paper page
  43. Holzenberger, 2011, Igf-I signaling and effects on longevity, Nestle Nutr Workshop Ser Pediatr Program, 68, 237, 10.1159/000325914 · DOI
  44. Bartke, 2011, Single-gene mutations and healthy ageing in mammals, Philos Trans R Soc Lond B Biol Sci, 366, 28, 10.1098/rstb.2010.0281 · DOI
  45. List, 2014, Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles, Endocrinology, 155, 1793, 10.1210/en.2013-2086 · DOI
  46. Sun, 2013, Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice, Elife, 2, e01098, 10.7554/eLife.01098 · DOI
  47. Hsieh, 2004, Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers, Mech Ageing Dev, 125, 785, 10.1016/j.mad.2004.07.008 · DOI · Paper page
  48. Vergara, 2004, Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant, J Gerontol A Biol Sci Med Sci, 59, 1244, 10.1093/gerona/59.12.1244 · DOI
  49. Murakami, 2003, Multiplex stress resistance in cells from long-lived dwarf mice, FASEB J, 17, 1565, 10.1096/fj.02-1092fje · DOI · Paper page
  50. Postic, 1999, Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase, J Biol Chem, 274, 305, 10.1074/jbc.274.1.305 · DOI · Paper page
  51. Chen, 2011, The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2, J Biol Chem, 286, 40386, 10.1074/jbc.M111.282590 · DOI
  52. Li, 2013, Direct and indirect effects of growth hormone receptor ablation on liver expression of xenobiotic metabolizing genes, Am J Physiol Endocrinol Metab, 305, E942, 10.1152/ajpendo.00304.2013 · DOI
  53. List, 2013, The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice, Mol Endocrinol, 27, 524, 10.1210/me.2012-1330 · DOI
  54. Partridge, 2011, Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network, Exp Gerontol, 46, 376, 10.1016/j.exger.2010.09.003 · DOI
  55. McCormick, 2011, TOR and ageing: a complex pathway for a complex process, Philos Trans R Soc Lond B Biol Sci, 366, 17, 10.1098/rstb.2010.0198 · DOI
  56. Cornu, 2013, mTOR in aging, metabolism, and cancer, Curr Opin Genet Dev, 23, 53, 10.1016/j.gde.2012.12.005 · DOI
  57. Li, 2014, Elevated ATF4 function in fibroblasts and liver of slow-aging mutant mice, J Gerontol A Biol Sci Med Sci
  58. Vesely, 2009, Translational regulation mechanisms of AP-1 proteins, Mutat Res, 682, 7, 10.1016/j.mrrev.2009.01.001 · DOI
  59. Jin, 2009, Activating transcription factor 4 and CCAAT/enhancer-binding protein-β negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress, Free Radic Biol Med, 46, 1158, 10.1016/j.freeradbiomed.2009.01.015 · DOI
  60. Ikenoue, 2008, Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling, EMBO J, 27, 1919, 10.1038/emboj.2008.119 · DOI
  61. Miller, 2014, Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction, Aging Cell, 13, 468, 10.1111/acel.12194 · DOI
  62. Harrison, 2014, Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males, Aging Cell, 13, 273, 10.1111/acel.12170 · DOI · Paper page
  63. Gu, 2011, Rictor/mTORC2 is essential for maintaining a balance between β-cell proliferation and cell size, Diabetes, 60, 827, 10.2337/db10-1194 · DOI
  64. Liu, 2014, Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity, Protein Cell, 5, 171, 10.1007/s13238-014-0021-8 · DOI
  65. Chen, 2013, Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism, J Biol Chem, 288, 27019, 10.1074/jbc.M113.498055 · DOI
  66. Shimono, 1999, N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant, Mech Dev, 83, 39, 10.1016/S0925-4773(99)00025-8 · DOI
  67. Qu, 2002, Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family, Mol Cell Biochem, 229, 35, 10.1023/A:1017934810825 · DOI
  68. Zhou, 2001, Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart, Genomics, 73, 86, 10.1006/geno.2000.6496 · DOI
  69. Park, 2000, Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells, Biochem Biophys Res Commun, 276, 321, 10.1006/bbrc.2000.3475 · DOI
  70. Zhou, 1998, Cap43, a novel gene specifically induced by Ni2+ compounds, Cancer Res, 58, 2182
  71. Yao, 2008, NDRG2: a Myc-repressed gene involved in cancer and cell stress, Acta Biochim Biophys Sin (Shanghai), 40, 625, 10.1111/j.1745-7270.2008.00434.x · DOI
  72. Ellen, 2008, NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states, Carcinogenesis, 29, 2, 10.1093/carcin/bgm200 · DOI
  73. Maruyama, 2006, Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis, Cancer Res, 66, 6233, 10.1158/0008-5472.CAN-06-0183 · DOI
  74. Nishio, 2008, Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma, Cancer Lett, 264, 36, 10.1016/j.canlet.2008.01.020 · DOI
  75. Gesing, 2014, Expression of apoptosis-related genes in liver-specific growth hormone receptor gene-disrupted mice is sex dependent, J Gerontol A Biol Sci Med Sci
  76. Huypens, 2007, Adipokines regulate systemic insulin sensitivity in accordance to existing energy reserves, Med Hypotheses, 69, 161, 10.1016/j.mehy.2006.10.053 · DOI

Cited by

Sorted by citations

See all 79

Metadata

Authors
Dominick, G., Berryman, D. E., List, E. O., Kopchick, J. J., Li, X., Miller, R. A., & Garcia, G. G.
Affiliations
  • Department of Molecular, Cellular, and Developmental Biology (G.D.), University of Michigan College of Literature, Science and the Arts, Ann Arbor, Michigan 48109
  • Edison Biotechnology Institute (D.E.B., E.O.L., J.J.K.), Ohio University, Athens, Ohio 45701
  • Department of Pathology (X.L., R.A.M., G.G.G.), University of Michigan School of Medicine Ann Arbor, Michigan 48109
Venue
Endocrinology
Publisher
The Endocrine Society
Published
2014-12-02
Volume
156
Issue
2
Pages
565-575
ISSN
  • 0013-7227
  • 1945-7170
DOI
10.1210/en.2014-1690
Cited by
79
References
11
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review